⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
AEP Inhibitors (CP#11A)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-16 — Endothelial C/EBPβ/AEP pathway drives vascular deterioration and systemic aging.: Mouse study: endothelial C/EBPβ/AEP activation cleaves NAMPT and depletes systemic NAD+, driving vascular deterioration, senescence, and shortened lifespan; genetic or pharmacologic AEP inhibition with CP#11A rescued vascular aging and outperformed NMN — preclinical only, no human data. [animal-model] (novelty: 4)
Open questions
Related
Contributing findings
Endothelial C/EBPβ/AEP pathway drives vascular deterioration and systemic aging.
16-sep-2026
novelty 4
per-area 4
strengthens